The Pharmacists’ Defence Association (PDA) will now be able to fully contribute to negotiations on the pay and conditions of NHS staff on Agenda for Change contracts, after becoming a full voting ...

The National Commission into the Regulation of AI in Healthcare report, published on 10 September 2026, told the government ...

Scotland’s first local drug-checking service will open in Glasgow in October 2026, allowing people to submit drugs for rapid ...

Scottish community pharmacies are among sites where a new video remote interpreting (VRI) app — which provides live British ...

When most people are diagnosed with type 1 diabetes, a clock has been counting down inside them for several years. Autoantibodies have been silently attacking insulin-producing beta cells in the ...

Around one in six children taking glucagon-like peptide-1 receptor agonists (GLP-1s) experiences a nutritional deficiency ...

The chairs of six parliamentary committees have asked the National Audit Office (NAO) to look into whether the pharmaceutical ...

The General Pharmaceutical Council (GPhC) is one of the healthcare regulators that has committed to jointly developing “high-level principles” around the regulation of artificial intelligence (AI) use ...

Community Pharmacy England (CPE), the Department of Health and Social Care (DHSC) and NHS England have begun “exploratory ...

The Royal College of Pharmacy (RCPharm) formally launched in April 2026 and with it came its first cohort of national pharmacy advisory council chairs. Mahendra Patel, Liz Hallett and Catriona ...

Since the approval of semaglutide (Wegovy; Novo Nordisk) as a weight-loss injection in the United States in 2021, the effect of GLP-1 medicines on the treatment of obesity has been undeniable. In the ...

The extension of the UK Rare Diseases Framework represents both progress and unfinished business. When it launched in 2021, the framework set out a shared ambition to address structural inequities ...